Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 8, 2026

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

[New developments in retinal detachment surgery].

U Bartz-Schmidt1, P Szurman, D Wong

  • 1Universitäts-Augenklinik Tübingen, Tübingen, Deutschland. u.bartz-schmidt@med.uni-tuebingen.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|January 23, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Unilateral recurrent elevation of intraocular pressure with hypopyon].

Die Ophthalmologie·2021
Same author

Alteration of MCP-1 and MMP-9 in Aqueous Humor Is Associated with Secondary Glaucoma in Fuchs Uveitis Syndrome.

Ocular immunology and inflammation·2019
Same author

[Laser flare photometry for identification of high-risk patients for proliferative vitreoretinopathy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same author

[Watchful waiting as a therapeutic principle for diseases of the vitreoretinal interface].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
Same author

[Vision Loss after Silicone Oil Surgery].

Klinische Monatsblatter fur Augenheilkunde·2017
Same author

Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.

Eye (London, England)·2016

Initial retinal detachment surgery outcomes depend on surgical approach. Modern vitrectomy techniques, including new trocar systems and tamponade methods, alongside pharmacologic therapies, are improving patient results, especially for proliferative vitreoretinopathy.

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Vitreoretinal Diseases

Context:

  • Initial surgical intervention is critical for retinal detachment outcomes.
  • Vitrectomy techniques are continuously evolving.
  • New advancements include minimally invasive trocar systems and novel tamponade strategies.

Purpose:

  • To review current strategies in primary vitrectomy surgery for retinal detachment.
  • To highlight recent advancements in surgical techniques and adjunct therapies.
  • To discuss the role of heavy silicone oils and pharmacologic agents in managing complex cases.

Summary:

  • Modern primary vitrectomy surgery for retinal detachment incorporates 25- and 23-gauge trocar systems.
  • Novel techniques avoid traditional tamponades like perfluorocarbons, gas, or silicone oil.

More Related Videos

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

Related Experiment Videos

Last Updated: Jul 8, 2026

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

  • Heavy silicone oils are increasingly used for inferior proliferative vitreoretinopathy (PVR) redetachments.
  • Pharmacologic adjuncts such as daunorubicin and 5-fluorouracil/low molecular weight heparin show promise in improving outcomes for PVR patients.

    • Impact:

    • These advancements aim to enhance both anatomic success and functional vision post-retinal detachment repair.
    • Minimally invasive techniques may reduce surgical trauma and improve patient recovery.
    • Targeted pharmacologic therapies offer new hope for managing challenging PVR cases.